Funder
National Natural Science Foundation of China
Jiangsu Provincial Key Research and Development Program
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference38 articles.
1. Castellanos JR, Purvis IJ, Labak CM, Guda MR, Asuthkar S (2017) B7-H3 role in the immune landscape of cancer. Am J Clin Exp Immunol 6(4):66–75
2. Flem-Karlsen K, Fodstad Y, Nunes-Xavier CE (2020) B7-H3 immune checkpoint protein in human cancer. Curr Med Chem 27(24):4062-4086
3. Yang S, Wei W, Zhao Q (2020) B7-H3, a checkpoint molecule, as a target for cancer immunotherapy. Int J Biol Sci 16(11):1767–1773
4. Picarda E, Ohaegbulam KC, Zang X (2016) Molecular pathways: targeting B7-H3 (CD276) for human cancer immunotherapy. Clin Cancer Res 22:3425–3431
5. Loo D, Alderson RF, Chen FZ, Huang L, Zhang W, Gorlatov S, Burke S, Ciccarone V, Li H, Yang Y (2012) Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activity. Clin Cancer Res 18(14):3834–3845
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献